Henry J. Fuchs, President, Worldwide R&D at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 12,000 shares at $90.43 ($1.1M) on 2023-08-10, disclosed to the SEC on 2023-08-11.
Open-market sale of $1.1M BMRN by President, Worldwide R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| MRTX | SELL | 2020-12-16 | $4.7M | — | Filing → |
| MRTX | SELL | 2020-08-11 | $1.6M | — | Filing → |
| BMRN | SELL | 2020-07-22 | $16.4M | — | Filing → |